InvestorsHub Logo
Followers 22
Posts 1379
Boards Moderated 0
Alias Born 03/31/2017

Re: None

Friday, 02/26/2021 6:57:13 AM

Friday, February 26, 2021 6:57:13 AM

Post# of 403568
Great post!

Go Leo & IPIX!

IPIX is no longer a start-up. It's been on the biotech scene for more than a decade. Any "financier" would only offer a predatory lending for a biotech on an OTC with a stock price hovering in the low pennies. If our CEO was not also one of the largest shareholders, the company would have already been sold off for peanuts, giving himself/herself an out of the door bonus...the interest of a majority of shareholders be damned.

It is interesting how these doubts are raised when the stock starts going down after a faux rally in the price. Investors claiming a large stake in the company now say they have taken a little off the table sowing more doubt.

What has changed really? The trials which will make (or break) this company have just started. I consider that as a positive. We are in a good financial position per the latest 10Q, which I would also consider positive. A partner for UP just announced the end of P1 and the initial stages for a P2. Again a positive. P2 for UC through the oral route will start this year. Hmmm...that again sounds positive to me.

The runway for day traders is getting shorter and shorter by the week. Therefore, the desperation is palpable. After all this stock has been a lunch money cash cow for more than a decade, and the thought of losing it may be disconcerting to some. So one last slog to get a final pay-off before the great reset.


Innovation Pharmaceuticals’ Brilacidin for the Treatment of COVID-19 Receives FDA Fast Track Designation

FDA Grants IND Approval for Phase 2 Clinical Trial of Innovation Pharmaceuticals - Brilacidin for Treating
COVID-19

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News